ACHV News and Press, Achieve Life Sciences Inc. From 02/25/19

Achieve Life Sciences (NASDAQ: ACHV ) -11% . More news on: Achieve Life Sciences, Inc., Riot Blockchain, Inc., McDermott International, Inc., Stocks on the move, Read more ...

Gainers: Achieve Life Sciences (NASDAQ: ACHV ) +78% . The Trade Desk (NASDAQ: TTD ) +31% . Wayfair (NYSE: W ) +29% . DMC Global (NASDAQ: BOOM ) +29% . Voyager Therapeutics (NASDAQ: VYGR ) +24% . Roku (NASDAQ: ROKU ) +23% . Universal Display (NASDAQ: OLED ) +23% . Zillow Group, Inc....

CORAL GABLES, FL / ACCESSWIRE / February 22, 2019 / The healthcare stock market has garnered significant attention over the last few months, as more companies in the industry are working to focus their efforts on developing new treatments for patients suffering from a variety of ailments. ...

Achieve Life Sciences (NASDAQ: ACHV ) +66%  on positive cytisinicline data . More news on: Achieve Life Sciences, Inc., Extraction Oil & Gas, Voyager Therapeutics, Stocks on the move, Read more ...

Thinly traded nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up  57%  premarket on robust volume in reaction to final data from a Phase 1/2 clinical trial evaluating smoking cessation med cytisinicline. The data are being presented today at the Society for Research on Nicoti...

SEATTLE and VANCOUVER, British Columbia , Feb. 22, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced final data f...

Achieve Life Sciences ( ACHV -1.5% ) has completed the enrollment of 254 subjects in a Phase 2b clinical trial, ORCA-1 , evaluating cytisinicline, plus behavioral support, for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more ...

SEATTLE and VANCOUVER, British Columbia , Feb. 20, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the completi...

Achieve Life Sciences, Inc. (ACHV) Q3 2018 Earnings Conference Call November 07, 2018, 04:30 PM ET Executives Jaime Welch - EVP, Commercial Richard Stewart - Chairman and CEO John Bencich - EVP, CFO and Operating Officer Cindy Jacobs - EVP and Chief Medical Officer Analysts ...

Achieve Life Sciences (NASDAQ: ACHV ): Q3 GAAP EPS of -$0.71. More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...